Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):377–385. doi: 10.1097/QAI.0000000000000500

Figure 4.

Figure 4

Evaluation of HIV-1 specific responses. Proportion of anti-HIV-1 IgG determined by BED-CEIA found in Elite Controllers (EC), Ebbing Elite Controllers (EEC), Viremic Controllers (VC) and Non-Controllers (NC) (A). Gag- (B) and Nef- (C) specific PBMC responses among Elite Controllers (EC), Ebbing Elite Controllers (EEC), Viremic Controllers (VC) and Non-Controllers (NC) by IFN-γ ELISpot (SFC/106 PBMC). Open circles represent patients with B*57 and open squares represent patients with B*27 alelles. Horizontal dashed line represents the conventional cut-off value (0.8) below which a sample is classified as recent infection (153-day window period) based on the low proportion of HIV-specific IgG in the serum/plasma. The horizontal bars denote median values. P values for comparison between two groups were calculated using a 2-tailed Mann-Whitney test.